• Home
  • NEW DAY MEDICINE
  • 7(45)2022
  • 45 — 7 (45) 2022 — Khaitov K.N., Makhmudov F.A., SIGNIFICANT SYMPTOMS BEFORE TREATMENT FOR CUTANEOUS LEISHMANIASIS

45 — 7 (45) 2022 — Khaitov K.N., Makhmudov F.A., SIGNIFICANT SYMPTOMS BEFORE TREATMENT FOR CUTANEOUS LEISHMANIASIS

SIGNIFICANT SYMPTOMS BEFORE TREATMENT FOR CUTANEOUS LEISHMANIASIS

Khaitov K.N., Bukhara State Medical Institute

Makhmudov F.A., Bukhara State Medical Institute

Rezyume

Leyshmaniozning tarqalish darajasi parazitar etiologiyali kasalliklar orasida birinchi oʼrinlardan birini egallaydi. Epidemiologik tadqiqotlar shuni ko’rsatdiki, teri leyshmaniozi ma’lum mavsumiylik bilan xarakterlanadi. Bemorlar ko’pincha shifokor huzuriga kech murojaat qilishadi. Ammo bemorni davolashdan oldin albatta leyshmaniozni klinik turini, yaralar joylashgan sohalar va yaralar sonini aniqlash kerakli muhim belgilardan biri bo’lib sanaladi.

Kalit so’zlar: Teri leyshmaniozi, klinik turi, limfangit, limfadenit, asoratlangan

First page

223

Last page

226

For citation: Khaitov K.N., Makhmudov F.A., SIGNIFICANT SYMPTOMS BEFORE TREATMENT FOR CUTANEOUS LEISHMANIASIS //New Day in Medicine 7(45)2022 223-226 https://l.clck.bar/25df8

LIST OF REFERENCES:

  1. Maxmudov, F. A., Raxmatov, O. B., Latipov, I. I., Rustamov, M. K., Sharapova, G. S. (2021). Intravenous laser blood irradiation in the complex treatment of patients with cutaneous leishmaniasis. 湖南大学学报 (自然科学版), 48(9).
  2. Махмудов Ф.А., Латипов И.И. (2019). Атопический дерматит: иммунопатогенез и стратегия иммунотерапии. Новый день в медицине, (4), 195-200.
  3. Maxmudov F.A., Latipov I.I. (2019). The immunopathogenesis of atopic dermatitis and strategy of immunotherapy. Новый день в медицине, (4), 53-57.
  4. Makhmudov F.A., Gulomova S.K. (2021). Changes in skin leishmaniasis after local treatment. ACADEMICIA: An International Multidisciplinary Research Journal, 11(1), 1744-1749.
  5. Axmedovich M.F., Samadovna S.G., Obidovich S.S. (2021, May). Observation of immunological changes during clinical cycles of skin leishmaniosis. In Euro-Asia Conferences (Vol. 5, No. 1, pp. 207-211).
  6. Rakhmatov O.B. (2021). Improving the principles of treatment in patients with zoonotic leishmaniasis with the immunomodulator gepon and methylene blue using the alt-vostok device. 湖南大学学报 (自然科学版), 48(9).
  7. Raxmatov O.B., Xayitova N.D. (2022). Husnbuzar kasalligini davolashda rux va doksisiklin dori preparatlarining birgalikdagi samaradorlikni aniqlash. Eurasian Journal of Medical and Natural Sciences, 2(1), 20-23.
  8. Рахматов О.Б., Юсупов Д.А. (2021). Бухоро вилоятида атопик дерматит касаллиги билан касалланганларнинг ёшга ва жинсга нисбатан ажратилиши. Scientific progress, 2(6), 1718-1729.
  9. Axmedovich M.F., Ikromovich L.I., Hamza o’g’li, O.J. (2021). Statistics of the incidence of cutaneous leishmaniasis in the Bukhara region, depending on age, gender and region. Middle European Scientific Bulletin, 17, 373-377.
  10. Axmedovich F.M., Amonovich D.Y. (2021). Clinical Criteria for the Manifestation of Atopic Dermatitis in Schoolchildren, Depending on Age. Central asian journal of medical and natural sciences, 2(5), 335-339.
  11. Махмудов Ф.А., Латипов И.И., Озодов Ж.Х., Юсупов Д.А. (2020). Vitiligo extent tensity index (veti) score: a new definition, assessment and treatment evaluation criteria in vitiligo. Новый день в медицине, (1), 276-279.
  12. Шаропова Г. С. (2022). Изучить Эффективность Экстракта Алоэ При Местном Применения Зоонозного Лейшманиоза. Central asian journal of medical and natural sciences, 2(7), 216-220.

file

download